<DOC>
	<DOC>NCT00905814</DOC>
	<brief_summary>The hypothesis of this study is that one 5 mg tablet of axitinib has similar drug concentrations in plasma compared to five 1 mg tablets of axitinib after oral dosing.</brief_summary>
	<brief_title>A Bioequivalence Study Of AG-013736 Tablets In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Axitinib</mesh_term>
	<criteria>Healthy male and/or female subjects between the ages of 21 and 47 years, inclusive (Healthy is defined as no clinically relevant abnormalities identified by a detailed medical history, full physical examination, including blood pressure and pulse rate measurement, 12lead electrocardiogram (ECG) and clinical laboratory tests). Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg (110 lbs). An informed consent document signed and dated by the subject or a legally acceptable representative. Evidence of significant disease of the blood, kidney, endocrine system, lungs, gastrointestinal, heart, liver, psychiatric, neurologic, or allergic (including drug allergies, but excluding season allergies). Active smokers or users of tobacco containing products and other drugs Pregnant or nursing females; females of childbearing potential including those with tubal ligation.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>47 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Bioequivalence</keyword>
</DOC>